One Center • One Focus • One Team

Oncology

HomeOncology

Takeaways from the 2016 ASCO Cancer Survivorship Symposium

On January 15, the American Society of Clinical Oncologists hosted the inaugural Survivorship Symposium in San Francisco. More than 800 doctors from numerous disciplines, researchers, patients and patient advocates gathered for the event focused on advancing cancer survivorship care issues. I recently wrote a joint article for Breast Cancer Social Media Community about the 2016 ASCO Survivorship Symposium with Stacey Tinianov, a breast cancer survivor and patient advocate.

Personalized Care for Cancer Survivors

One theme at the 2016 ASCO Survivorship Symposium was “One Size Fits No One.” There are more than 14 million cancer survivors in the United States and their needs vary. Several presentations revolved around the need for a […]

Developments in Multi-Gene Panel Tests for Breast Cancer

Numerous genetic mutations are linked to increased risk for breast cancer. Genetic testing can identify these mutations and guide patient management decisions. Over the past decade, multi-gene panel tests have gained traction in clinical settings. These evaluate up to 43 breast cancer-related genes, compared with limited BRCA 1 and BRCA2 (BRCA1/2) tests. In a recent review for World Journal of Surgical Procedures, I discussed whether multi-gene panel testing should replace limited BRCA1/2 testing.

Background to Genetic Testing

Since the mid-1990s, we have known about the link between BRCA1/2 and risk for breast cancer, which account for 30 to 50 percent of breast cancers. There are now well-established clinical guidelines for the […]

The Impact of Multi-Gene Panel Testing for Cancer Survivors

Multi-gene panel testing has recently emerged as a safe and effective way to identify genetic mutations known to increase risk for breast cancer. Compared with earlier genetic tests, which required initial testing for BRCA1 and BRCA2 followed by subsequent testing for other cancer-related genes, multi-gene panel testing can evaluate up to 43 genes. At Breastlink, we recently conducted a study to see how multi-gene panel testing affected treatment and screening decisions in cancer survivors who had previously tested negative for BRCA1/2.

IMG_3923 edited

How Does Management Change for Cancer Survivors with Positive Results?

For our study, we retrospectively collected data from 914 Breastlink patients who […]

Trends in Ductal Carcinoma In Situ Survival Rates

The long-term survival rate for women diagnosed with ductal carcinoma in situ (DCIS) or non-invasive breast cancer is excellent, according to a new study released in August. The study, “Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ” revealed that this held true regardless of the type of treatment. […]

By |December 21, 2015|Categories: Cancer News, Oncology|0 Comments

Breastlink Research at the 2015 San Antonio Breast Cancer Symposium

Every year, the San Antonio Breast Cancer Symposium (SABCS) hosts one of the most important breast cancer conferences in the world. Experts across various specialties gather to share updates in cutting-edge breast cancer treatments and interventions. At the 2015 SABCS, Breastlink joined the discussion to share research we’ve been working on with patients in Orange County.

I had the opportunity to present a research poster and host a discussion on the results of a Breastlink study that I led: “Multi-gene panel testing and the cancers identified in patients at risk for hereditary breast cancer.” Dr. John Link presented a research poster based on another study we conducted: “The Breast Cancer Index […]

The 2015 ASCO Breast Cancer Symposium in Review

Every year, the American Society of Clinical Oncologists hosts a Breast Cancer Symposium to promote discussion about developments in breast cancer care and treatment. This event is an exceptional opportunity to learn about current trends and future directions that affect our patients and our daily practice. I was excited to attend the 2015 ASCO Breast Cancer Symposium and appreciate the thought-provoking dialogue that occurred.  In addition, I was also invited to present our own data on multi-gene panel testing.

Several topics of interest included the development of a new model for evaluating breast cancer risk in women with atypical hyperplasia, new data on recurrence in women with ductal carcinoma in situ […]

Chemotherapy Side Effects in Breast Cancer Patients

Medical advancements allow us to treat breast cancer more effectively than ever before. However, side effects can occur as a result of treatment. Many breast cancer patients receive some combination of surgery, radiation therapy and chemotherapy. Chemotherapy side effects can range from being a temporary nuisance to having a sustained negative impact on quality of life. As oncologists, it is our job to help patients avoid, lessen or completely eliminate such side effects. […]

By |November 9, 2015|Categories: Oncology|0 Comments

Chemotherapy for Breast Cancer

Chemotherapy is one of the most common treatment methods for fighting breast cancer. Typically used in combination with surgery, chemotherapy helps to kill breast cancer cells whether they reside within the breast or have managed to escape throughout the body. […]

By |October 26, 2015|Categories: Oncology|0 Comments

Breastlink Partners with Researchers to Explore Atezolizumab in Triple-Negative Breast Cancer Patients

Breastlink has partnered with researchers to explore an investigational cancer immunotherapy called atezolizumab (MPDL3280A) in the treatment of metastatic triple-negative breast cancer. In early-stage trials, atezolizmab was effective in patients previously treated for triple-negative breast cancer. A new trial will investigate atezolizumab with chemotherapy in metastatic triple-negative breast cancer patients who have not received prior systemic therapy for incurable disease. […]

Addressing Some Questions About Breast Cancer

One of the things I love most about my job is the opportunity afforded to me to be involved in educating patients. Every year, Susan G. Komen® Orange County hosts a series of educational lectures to help patients better understand breast cancer. Events such as these offer me an opportunity to reach out to many at once. This year, I was honored to speak as part of this series to help answer some questions about breast cancer. For those who were unable to attend, some of the topics discussed are addressed below. […]

Load More Posts